SCHEMBL291695

SCHEMBL291695

CC(C)(C)OC(=O)N1CC(=O)N(c2ccccc2Cl)CC1(C)C

nearest known ligand 0.48

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
REN P00797 18/20 0.45
CYBB P04839 1/20 0.41
NOX5 Q96PH1 1/20 0.41
NOX4 Q9NPH5 1/20 0.41
NOX1 Q9Y5S8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292987 0.87 MAPT (0.41) REN
SCHEMBL292245 0.87 NR1H2 (0.39) REN
SCHEMBL293228 0.85 REN (0.44) REN
SCHEMBL291814 0.84 REN (0.44) REN
SCHEMBL27776020 0.83 HDAC1 (0.36) REN
SCHEMBL292539 0.83 NR1H2 (0.45) REN
SCHEMBL293149 0.82 SCN9A (0.41) REN
SCHEMBL293123 0.81 REN (0.48) REN
SCHEMBL291388 0.80 REN (0.48) REN
SCHEMBL291213 0.80 SNRNP200 (0.41) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101511799-B Cyclic amine compound DAIICHI SANKYO CO LTD 2012-05-30 CN disclosed
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
CN-101511799-A Cyclic amine compound DAIICHI SANKYO CO LTD (JP) 2009-08-19 CN disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 REN 35/4885CYBB 925/4885NOX5 975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.